PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

China grants conditional market approval for Sinopharm CNBG’s COVID-19 vaccine

The inactivated COVID-19 vaccine developed by Beijing Institute of Biological Products of Sinopharm CNBG has been granted conditional registration by the NMPA of Chi...
Continue Reading →
News

Seraphina Therapeutics launches Fatty15 geriatric dietary supplement

Fatty15 is the first product based on C15:0, a micronutrient recently discovered to be critical to maintaining health Image source: PR Newswire Seraphina Therape...
Continue Reading →
News

Intravacc and Cristal Therapeutics Announce Strategic Collaboration to Advance Novel Vaccine Platforms

First joint CriVac® vaccine candidate to target receptor-binding domain of SARS-CoV-2Evaluation of Cristal’s CliCr® and Intravacc’s OMV technology  Intravacc, a wo...
Continue Reading →
News

Moderna provides COVID-19 vaccine supply update

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, provided a supply update for the Moderna COVID-19 Va...
Continue Reading →
News

Pfizer and BioNTech to supply the European Union with 100 million additional doses of COMIRNATY®

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced they will supply an additional 100 million doses of COMIRNATY®, the companies' COVID-19 Vaccine, to ...
Continue Reading →
News

Sukino Healthcare offers post-COVID-19 multidisciplinary rehabilitative treatment

The treatment is an amalgamation of physio, occupational and respiratory therapy Sukino Healthcare, India’s first and only continuum care provider, has announce...
Continue Reading →
News

Avacta submits clinical trial application for AVA6000 pro-doxorubixin

A Phase 1 dose-escalation and expansion study of Avacta’s novel pre|CISION™ FAP-activated Doxorubicin prodrug Avacta Group plc (AIM: AVCT), the developer of innova...
Continue Reading →
News

MHRA approves Polyphor’s phase 1 trial of novel inhaled antibiotic

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Swiss biotech Polyphor’s first-in-human phase I study of its novel inhaled antibio...
Continue Reading →
News

Pfizer, BioNTech win EU authorisation for COVID-19 vaccine Comirnaty

The European Commission (EC) has granted Pfizer/BioNTech’s COVID-19 vaccine a conditional marketing authorisation (CMA), under the new name Comirnaty. The vaccine,...
Continue Reading →
News

SHIONOGI’S NOVEL ANTIBIOTIC, FETCROJA® (CEFIDEROCOL), HAS BEEN SELECTED BY UK’S NICE / NHSE&I AS PART OF AN ANTIMICROBIAL SUBSCRIPTION STYLE REIMBURSEMENT MODEL

The National Institute for Clinical and Health Excellence (NICE) and the National Health Service England and Improvement (NHSE&I) have recognised the potential o...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026